- Home
- ORMP
ORMP
Oramed Pharmaceuticals Inc.
as 12-20-2024 4:00pm EST
| Founded: | 2002 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 224.4K |
| Analyst Decision: | Hold | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.11 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.00 - $3.67 | Next Earning Date: | 12-31-2024 |
| Revenue: | N/A | Revenue Growth: | -50.43% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Oramed Pharmaceuticals Inc. News
ORMP Breaking Stock News: Dive into ORMP Ticker-Specific Updates for Smart Investing
Simply Wall St.
18 days ago
3 US Penny Stocks With Market Caps Above $40M
Zacks Small Cap Research
20 days ago
ORMP: Preparations for New Phase 3 Trial Advance, While ORMP Leverages Balance Sheet Through Recent Agreements
Simply Wall St.
2 months ago
US Penny Stocks To Watch: 3 Picks With Market Caps Over $40M
MT Newswires
3 months ago
Scilex Holding Starts $50 Million Registered Direct Offering of Convertible Notes
PR Newswire
3 months ago
Oramed Pharmaceuticals Announces Restructuring of Scilex Holding Company Debt
MT Newswires
3 months ago
Scilex Holding to Pay $2 Million to Oramed Pharmaceuticals in Loan Accord
Zacks Small Cap Research
4 months ago
ORMP: Balance Sheet Strong, Potential Benefits of Investments, JVs, Buybacks
Associated Press Finance
4 months ago
Oramed: Q2 Earnings Snapshot
Compare ORMP vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ORMP Oramed Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.